Citations 952
Faculty Opinions recommendation of Immune therapy of metastatic melanoma developing after allogeneic bone marrow transplant.
Ansell, Stephen M.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | April 20, 2016 | Volume: No volume available | Issue: No issue available | Pages: No page available
Faculty Opinions recommendation of Major clinical response to nivolumab in relapsed/refractory Hodgkin lymphoma after allogeneic stem cell transplantation.
Ansell, Stephen M.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | April 20, 2016 | Volume: No volume available | Issue: No issue available | Pages: No page available
Faculty Opinions recommendation of Ipilimumab therapy in patients with advanced melanoma and preexisting autoimmune disorders.
Ansell, Stephen M.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | April 20, 2016 | Volume: No volume available | Issue: No issue available | Pages: No page available
Faculty Opinions recommendation of Nivolumab in a patient with refractory Hodgkin's lymphoma after allogeneic stem cell transplantation.
Ansell, Stephen M.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | April 20, 2016 | Volume: No volume available | Issue: No issue available | Pages: No page available
Faculty Opinions recommendation of Chimeric antigen receptor T cells for sustained remissions in leukemia.
Ansell, Stephen M.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | April 20, 2016 | Volume: No volume available | Issue: No issue available | Pages: No page available
Faculty Opinions recommendation of Mitigating the toxic effects of anticancer immunotherapy.
Ansell, Stephen M.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | April 20, 2016 | Volume: No volume available | Issue: No issue available | Pages: No page available
Faculty Opinions recommendation of 90Y-daclizumab, an anti-CD25 monoclonal antibody, provided responses in 50% of patients with relapsed Hodgkin's lymphoma.
Ansell, Stephen M.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | April 20, 2016 | Volume: No volume available | Issue: No issue available | Pages: No page available
Faculty Opinions recommendation of Pancreatitis in patients treated with brentuximab vedotin: a previously unrecognized serious adverse event.
Ansell, Stephen M.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | April 20, 2016 | Volume: No volume available | Issue: No issue available | Pages: No page available
Faculty Opinions recommendation of Cancer statistics, 2016.
Ansell, Stephen M.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | April 20, 2016 | Volume: No volume available | Issue: No issue available | Pages: No page available
Faculty Opinions recommendation of Lymphoma incidence, survival and prevalence 2004-2014: sub-type analyses from the UK's Haematological Malignancy Research Network.
Ansell, Stephen M.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | April 20, 2016 | Volume: No volume available | Issue: No issue available | Pages: No page available